Moreover, PRRFY is currently trading at 99.7% of its 52-week High-Low Range, hinting that it can be on the verge of a breakout. Looking at the fundamentals, the stock currently carries a Zacks Rank #2 (Buy), which means it is in the top 20% of more than the 4,000 stocks that we rank based on trends in earnings estimate revisions and EPS surprises -- the key factors that impact a stock's near-term price movements. The Zacks Rank stock-rating system, which uses four factors related to earnings estimates to cl ...

NEW YORK, May 17, 2024 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced the successful exhibition of its Intelligent Fingerprinting Drug Screening Solution at The Health & Safety Event 2024, the United Kingdom's largest annual technology showcase exhibiting products and services that strengthen and support workplace safety standards. According to the event w ...

SANTA CLARA, Calif. and PUNE, India, May 16, 2024 /PRNewswire/ -- Persistent Systems(BSE: PERSISTENT) (NSE: PERSISTENT), a global Digital Engineering and Enterprise Modernization leader, today announced that it achieved Premier Services Partner status with Snowflake, the Data Cloud company. As a Premier Services Partner, Persistent will be able to accelerate clients' data journeys, enabling them to leverage the Snowflake Data Cloud's flexibility, accuracy, and scalability. It reaffirms the Company's commitm ...

Exhibit 99.1 Premier, Inc. Reports Fiscal-Year 2024 Third-Quarter Results CHARLOTTE, N.C., May 7, 2024 - Premier, Inc. (NASDAQ: PINC), a leading technology-driven healthcare improvement company, today reported financial results for the fiscal-year 2024 third quarter ended March 31, 2024. Third-quarter results: "Our third quarter results, which exceeded our expectations for profitability, reflect ongoing adoption of our products and services by members and other customers," said Michael J. Alkire, Premier's ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 (Exact name of registrant as specified in its charter) Delaware 35-2477140 (State or other jurisdiction of incorporation or organization) 13034 Ballantyne Corporate Place Charlotte, North Carolina 28277 (Address of principal executive offices) (Zip Code) (704) 357-0022 (Registrant's ...

Paid dividends of $73.1 million to stockholders in first nine months of 2024 Board declared a dividend of $0.21 per share, payable on June 15, 2024, to stockholders of record as of June 1, 2024 The company does not meaningfully reconcile guidance for non-GAAP adjusted EBITDA and non-GAAP adjusted earnings per share to net income attributable to stockholders or earnings per share attributable to stockholders because the company cannot provide guidance for the more significant reconciling items between net in ...

Financial Performance - Net revenue for the three months ended December 31, 2023, was $334.745 million, a decrease of 6.8% compared to $359.626 million in the same period of 2022[22]. - Gross profit for the six months ended December 31, 2023, was $431.865 million, down from $444.726 million in the prior year, reflecting a decrease of 2.9%[22]. - Operating income for the three months ended December 31, 2023, was $65.693 million, a decline of 25.4% from $88.166 million in the same quarter of 2022[22]. - Net income attributable to stockholders for the three months ended December 31, 2023, was $54.302 million, compared to $64.046 million in the same period of 2022, representing a decrease of 15.8%[22]. - Basic earnings per share for the three months ended December 31, 2023, was $0.45, down from $0.54 in the same quarter of 2022, a decrease of 16.7%[22]. - Net income for the six months ended December 31, 2023, was $95.276 million, a decrease of 11.5% compared to $107.333 million in 2022[26]. - Total segment net revenue for the six months ended December 31, 2023, was $653.622 million, down from $673.518 million in 2022, indicating a decrease of 3%[103]. Assets and Liabilities - Total assets increased to $3,832,528, up from $3,371,487 as of June 30, 2023, representing a growth of approximately 13.7%[20]. - Total current assets reached $990,257, compared to $641,626 at the end of June 2023, marking an increase of 54.3%[20]. - Total liabilities increased to $1,442,319 from $1,037,132, reflecting a rise of 38.9%[20]. - Stockholders' equity grew to $2,390,209, up from $2,334,355, which is an increase of 2.4%[20]. - Cash and cash equivalents rose significantly to $371,110 from $89,793, indicating a substantial increase of 314.5%[20]. - Cash equivalents increased significantly from $77,000 on June 30, 2023, to $147.6 million on December 31, 2023[48]. - The total assets rose from $55.6 million on June 30, 2023, to $202.8 million on December 31, 2023[48]. - The total debt and notes payable decreased to $152.60 million as of December 31, 2023, from $418.47 million as of June 30, 2023, indicating a reduction of approximately 63.6%[70]. Cash Flow - Net cash provided by operating activities decreased significantly to $35.380 million from $196.725 million, reflecting a decline of 82.0%[26]. - The company reported a net cash used in investing activities of $49.068 million, down from $227.466 million in the previous year[26]. - Net cash provided by financing activities increased to $294.982 million from $39.230 million, indicating a substantial rise[26]. - Cash and cash equivalents at the end of the period were $371.110 million, compared to $94.623 million at the end of the previous year[26]. Acquisitions and Impairments - The company recorded a pre-tax goodwill impairment charge of $54.4 million related to the Contigo Health reporting unit, including goodwill from the TRPN acquisition[40]. - The TRPN acquisition involved a purchase price of $177.5 million, funded through borrowings and cash on hand[38]. - The total fair value assigned to intangible assets acquired in the TRPN acquisition was $116.6 million, primarily related to the provider network[39]. - The company’s investments in unconsolidated affiliates showed a net loss of $2.392 million for the six months ended December 31, 2023[42]. Dividends and Share Repurchase - The company declared dividends of $0.21 per share during the reporting period[24]. - The company entered into an accelerated share repurchase agreement to repurchase $400,000,000 of its Class A common stock[113]. Expenses - Total operating expenses for the three months ended December 31, 2023, were $155.590 million, slightly up from $154.575 million in the same period of 2022[22]. - Stock-based compensation expense for the three months ended December 31, 2023, was $8.378 million, compared to $2.679 million for the same period in 2022, representing a 212% increase[89]. - Total stock-based compensation expense, net of tax, for the six months ended December 31, 2023, was $12.144 million, up from $7.808 million in 2022, reflecting a 55% increase[89]. Future Outlook and Risks - Future growth may be influenced by the ability to maintain strategic alliances and timely offer new products and services[11]. - The company faces risks related to competition and potential delays in revenue recognition due to extended sales cycles[11].

Premier, Inc. (NASDAQ:PINC) Q2 2024 Earnings Conference Call February 6, 2024 8:00 AM ET Company Participants Ben Krasinski - Senior Director, Investor Relations Michael Alkire - President and Chief Executive Officer Craig McKasson - Chief Financial Officer and Chief Administrative Officer Conference Call Participants Stephanie Davis - Barclays Richard Close - Canaccord Genuity Kevin Caliendo - UBS Allen Lutz - Bank of America Eric Coldwell - Baird Jessica Tassan - Piper Sandler William Sutherland - Benchma ...

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 UNITED STATES For the quarterly period ended September 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-36092 Premier, Inc. (Exact name of registrant as specified in its charter) Delaware 35-2477140 (State or other jurisdiction ...

Premier, Inc. (NASDAQ:PINC) Q1 2024 Earnings Conference Call November 7, 2023 8:00 AM ET Company Participants Ben Krasinski - Senior Director, Investor Relations Mike Alkire - President and Chief Executive Officer Craig McKasson - Chief Administrative Officer and Chief Financial Officer Leigh Anderson - President, Performance Services Conference Call Participants Eric Percher - Nephron Research Jessica Tassan - Piper Sandler Allen Lutz - Bank of America Operator Good morning, and welcome to Premier's Fiscal ...